Épissage constitutif et alternatif. A) Schéma d’un événement d’épissage. L’intron excisé mène à la production d’un ARNm mature qui est exporté au cytoplasme. d’une dizaine d’éléments contrôlant l’épissage alternatif des exons mutuellement exclusifs IIIb et IIIc de FGFR2 ont été identifiés (figure 3A). Bien que les. Causes d’altération de l’épissage alternatif dans les cancers. A) Mutations affectant l’épissage alternatif et quelques exemples de gènes ayant subi ce type de.
|Published (Last):||23 June 2012|
|PDF File Size:||4.54 Mb|
|ePub File Size:||4.47 Mb|
|Price:||Free* [*Free Regsitration Required]|
It is a method of producing structurally and functionally distinct proteins from the same gene and a method of developmental regulation.
Splicing factors and spliceosome components recognize splicing signals and regulatory sequences of the pre-mRNAs. Data akternatif to usage on the plateform after Although many alterations are caused by mutations in splicing sequence i.
Alternative splicing and tumor progression
Services Articles citing this article CrossRef 2. Language Portal of Canada Access a collection of Canadian resources on all aspects of English and French, including quizzes. Document Actions Export Bibliography. Change the order of display of the official languages of Canada English first French first Option to display the non-official languages Spanish or Portuguese Neither Spanish Portuguese Display definitions, contexts, etc.
Here we discover a class of human genes, in which the last exon appeared recently during evolution, and the major gene product uses an alternative 3′-terminal exon corresponding to the ancestral last exon of the gene. Current usage metrics About article metrics Return to article. This novel class of alternative 3′-terminal exons are downregulated on a large scale by doxorubicin, a cytostatic drug targeting topoisomerase II, and play a role in cell cycle regulation, including centromere-kinetochore assembly.
Epissage Alternatif by Peter Oriane on Prezi
Alternative 3′-terminal exons, which use intronic polyadenylation sites, are generally less conserved and expressed at lower levels than the last exon of genes. This mechanism is highly regulated to precisely modulate detection of specific splice sites.
These findings provide new insights into the evolution, function andmolecular regulation of alternative 3′-terminal exons. Glossaries and vocabularies Access Translation Bureau glossaries and vocabularies. Abstract Alternative 3′-terminal exons, which use intronic polyadenylation sites, are generally less conserved and expressed at lower levels than the last exon of genes.
Info A recently evolved class of alternative 3′-terminal exons involved in cell cycle regulation by topoisomerase inhibitors. Med Sci Paris ; This regulation is under control of the spliceosome and several splicing factors are also required to modulate the alternative usage of splice sites.
Examples of associations between human rare diseases and defects in pre-messenger RNA splicing are accumulating. HuR binding to the epixsage 3′-terminal exon in epussage pre-messenger RNA promotes its splicing, and is reduced by topoisomerase inhibitors.
Metrics Show article metrics.
Following growing of knowledge regarding splicing regulation, several approaches have been developed to compensate for the effect of altegnatif mutations and to restore sufficient amounts of functional protein.
Initial download of the metrics may take a while. Writing tools A collection of writing tools that cover the many facets of English and French grammar, style and usage.
The generation of two or more different mature mRNA’s from the same primary transcript through variation in the sites of splicing. In which subject field? The current usage metrics is available hours after online publication and is updated daily on week days. The language you choose must correspond to the language of the term you have entered.
A collection of writing tools that cover the many facets of English and French grammar, style and usage. Link to PubMed entry. Search Site only in current section. Skip to navigation Personal tools Log in. FAQ Frequently asked questions Display options. Previous article Next article.